PRME

Prime Medicine · Nasdaq · USA

Cap tier

Small

Approx cap

$0.4B

Bull scenarios

Adverse scenarios

Themes & clusters

From SRC_B Theme-Company Matrix

C10AI-discovered Drugs PipelineEpigenetic Reprogramming

From SRC_B Company Master

Most precise editing method; first-mover

Predictions where this ticker benefits

Pred	Role	Domain	Prediction	Predictor	Current	Move	Impact	Status
FUT_023	pure_play	Geopolitics	'Demographic bifurcation' 2026-2031: widening divides in size, growth, and structure of populations globally — creates extreme socioeconomic friction between aging wealthy nations (US, EU, Japan, Korea, China) and younger resource-starved regions (Afri...	Ian Bremmer	68.1%	unknown	unknown	in_progress
FUT_015	pure_play	Geopolitics	Era of 'multipolarity without multilateralism' defining 2026-2031 per Eurasia Group + WEF Global Risks Report — power highly distributed among regional hegemons but international cooperation mechanisms (UN, WTO) functionally collapsed. Exacerbated by '...	Ian Bremmer	61.8%	unknown	unknown	in_progress
IND_005	pure_play	Biotech/Longevity	Convergence of computational biology + AI-driven data modeling + CRISPR gene editing enables bringing back extinct species — Form Bio platform (spun out 2022) enables successful resurrection of woolly mammoth and Tasmanian tiger within the decade (by ~...	Ben Lamm	32.5%	unknown	unknown	in_progress
AUT_027	pure_play	Biotech/Longevity	Integration of AI with advanced bio-sensing, quantum computing, and genomics enables humanity to achieve 'Longevity Escape Velocity' — tipping point where medical technology extends human lifespan faster than time passes; continuous biological surveill...	Peter Diamandis	20.9%	unknown	unknown	pending

Predictions where this ticker is displaced

Pred	Domain	Prediction	Predictor	Current	Move	Impact	Mechanism
No adverse scenarios